Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Cureus
|
June 23, 2020
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: A Case Report
Ammar Al-Obaidi, Nathaniel A Parker, Khalil Choucair, et al.
BMC Cancer
|
November 23, 2012
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
Khalil Choucair, Joshua Ejdelman, Fadi Brimo, et al.
Cureus
|
June 17, 2020
A Case of Acute Heart Failure Following Immunotherapy for Metastatic Lung Cancer
Ammar Al-Obaidi, Nathaniel A Parker, Khalil Choucair, et al.
International Journal of Molecular Sciences
|
November 27, 2025
An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors
Khalil Choucair, Roupen Odabashian, Sushmita Nanja Reddy, et al.
The Oncologist
|
July 5, 2022
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology
Khalil Choucair, Abdul Rafeh Naqash, Caroline A Nebhan, et al.
Clinical Lung Cancer
|
November 21, 2025
Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis
Khalil Choucair, Hyejeong Jang, Shadia I Jalal, et al.
Future Science OA
|
March 26, 2019
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani, Khalil Choucair, Mushtaq Ashraf, et al.
Cancer Gene Therapy
|
January 29, 2020
PIK3CA gene aberrancy and role in targeted therapy of solid malignancies
Owen Willis, Khalil Choucair, Abdurahman Alloghbi, et al.
Anticancer Research
|
December 31, 2021
Pre-operative Carboplatin/Paclitaxel <i>Versus</i> 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
Mohammed Al-Jumayli, Khalil Choucair, Ammar Al-Obaidi, et al.
Cancer Gene Therapy
|
November 17, 2021
Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy
Elyssa Sliheet, Molly Robinson, Susan Morand, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Cureus
|
June 23, 2020
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: A Case Report
Ammar Al-Obaidi, Nathaniel A Parker, Khalil Choucair, et al.
BMC Cancer
|
November 23, 2012
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
Khalil Choucair, Joshua Ejdelman, Fadi Brimo, et al.
Cureus
|
June 17, 2020
A Case of Acute Heart Failure Following Immunotherapy for Metastatic Lung Cancer
Ammar Al-Obaidi, Nathaniel A Parker, Khalil Choucair, et al.
International Journal of Molecular Sciences
|
November 27, 2025
An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors
Khalil Choucair, Roupen Odabashian, Sushmita Nanja Reddy, et al.
The Oncologist
|
July 5, 2022
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology
Khalil Choucair, Abdul Rafeh Naqash, Caroline A Nebhan, et al.
Clinical Lung Cancer
|
November 21, 2025
Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis
Khalil Choucair, Hyejeong Jang, Shadia I Jalal, et al.
Future Science OA
|
March 26, 2019
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani, Khalil Choucair, Mushtaq Ashraf, et al.
Cancer Gene Therapy
|
January 29, 2020
PIK3CA gene aberrancy and role in targeted therapy of solid malignancies
Owen Willis, Khalil Choucair, Abdurahman Alloghbi, et al.
Anticancer Research
|
December 31, 2021
Pre-operative Carboplatin/Paclitaxel <i>Versus</i> 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer
Mohammed Al-Jumayli, Khalil Choucair, Ammar Al-Obaidi, et al.
Cancer Gene Therapy
|
November 17, 2021
Network based analysis identifies TP53m-BRCA1/2wt-homologous recombination proficient (HRP) population with enhanced susceptibility to Vigil immunotherapy
Elyssa Sliheet, Molly Robinson, Susan Morand, et al.
Page
of 4